155 related articles for article (PubMed ID: 38658965)
1. H
Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
[TBL] [Abstract][Full Text] [Related]
2. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
Yu J; Zhang X; Pei Z; Shuai Q
J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960
[TBL] [Abstract][Full Text] [Related]
3. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid-Fe@BSA nanoparticles for endogenous H
Tian Q; An L; Tian Q; Lin J; Yang S
Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
[No Abstract] [Full Text] [Related]
5. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer.
Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108
[TBL] [Abstract][Full Text] [Related]
6. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
8. ZnS@ZIF-8 core-shell nanoparticles incorporated with ICG and TPZ to enable H
Fang C; Cen D; Wang Y; Wu Y; Cai X; Li X; Han G
Theranostics; 2020; 10(17):7671-7682. PubMed ID: 32685012
[TBL] [Abstract][Full Text] [Related]
9. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
10. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
[TBL] [Abstract][Full Text] [Related]
11. Depletion and Downregulation of Hydrogen Sulfide Using an Activatable Probe for Promoting Photothermal Therapy toward Colorectal Cancers.
Dong X; Wu H; Zhang Z; Sun J; Dong C; Sun L; Wang R; Gu X; Zhao C
J Med Chem; 2024 May; 67(9):7431-7442. PubMed ID: 38664896
[TBL] [Abstract][Full Text] [Related]
12. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
[TBL] [Abstract][Full Text] [Related]
13. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
[TBL] [Abstract][Full Text] [Related]
14. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
[TBL] [Abstract][Full Text] [Related]
16. Sulourea-coordinated Pd nanocubes for NIR-responsive photothermal/H
Guo X; Liu J; Jiang L; Gong W; Wu H; He Q
J Nanobiotechnology; 2021 Oct; 19(1):321. PubMed ID: 34649589
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
18. A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy.
Hao Y; Gao Y; Fan Y; Zhang C; Zhan M; Cao X; Shi X; Guo R
J Nanobiotechnology; 2022 Jan; 20(1):43. PubMed ID: 35062953
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
[TBL] [Abstract][Full Text] [Related]
20. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
